dnc-emails
-----BEGIN PGP PUBLIC KEY BLOCK-----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=5a6T
-----END PGP PUBLIC KEY BLOCK-----
By Dan Diamond | 04/27/2016 10:00 AM EDT
There's Republican infighting over Zika funding, and CDC just dropped a massive report crammed with national health data. But first: A preview of today's bruising Senate hearing on drug prices.
WHAT VALEANT CEO WILL TELL THE SENATE: WE WERE 'TOO AGGRESSIVE' ON PRICE INCREASE - That's according to prepared testimony from Michael Pearson, who's striking a conciliatory tone ahead of the Senate Aging Committee's hearing on drug prices this afternoon, Pro's Sarah Karlin-Smith reports.
- Regrets? The outgoing CEO has a few. The infamous drug company has made "mistakes" Pearson writes, particularly being "too aggressive in pursuing price increases on certain drugs." He also regrets pursuing transactions where a "central premise" was to buy older drugs and increase the price.
- But he also thinks the Senate's getting Valeant's story wrong. Pearson tried to frame the Valeant drug price hikes as outliers, noting the committee's investigation has focused on just three of the company's 1,800 products. He also emphasized Valeant's investment in R&D and its commitment to programs that assist patients in paying for drugs.
- Moving forward. Pearson may be leaving Valeant, but he said the company is working to rethink its approach to drug pricing, and that it will "track industry norms." And he testifies that its new policies will involve greater formality and "reflect the painful lesson we have learned over the last year."
More details and witness list for the hearing, which starts at 3:30 p.m. ET: http://go.politicoemail.com/?qs=b4f8aeb80d0765d918f2e7de5a50004ad995c7f3f4a8edf5a4e1c99a2facdd4e
See Pearson's testimony.
12.2 percent. That's how much drug list prices went up last year, according to a recent IMS Health report - and don't be surprised to hear that number cited at today's hearing. But it's worth noting that list prices don't account for the discounts and rebates that many patients, providers and insurers receive to defray the cost of the drugs.
WHAT HOUSE DEMS ARE SAYING TO VALEANT: YOU'RE NOT PLAYING BALL - A memo from the House Oversight Committee Democrats obtained by POLITICO indicates Valeant is not fully cooperating with its investigation in drug price hikes.
According to the memo, Valeant withheld documents from the committee claiming they were protected by attorney-client privilege, but it later became clear that the documents weren't covered by that privilege. These documents, which included financial analyst reports prepared by multiple firms, indicate "that the U.S. government is now paying the company more than $1 billion a year because of its massive price increases," the Democrats argue.
- Valeant as symptom of bigger issues. The documents also show how widespread these abuses are across the entire drug industry, Ranking Member Elijah Cummings told POLITICO. The memo indicates that members have ongoing concerns about other documents the company continues to withhold from the House committee too.
WELCOME TO WEDNESDAY PULSE - Where I'm still counting the votes from last night's primaries. Tips to [email protected] or @ddiamond on Twitter.
With help from Sarah Karlin-Smith (@SarahKarlin).
ZIKA FUNDING: LOTS OF SPARRING, NOT A LOT OF PROGRESS - Sens. Lindsey Graham and Roy Blunt on Tuesday took a dig at their Republican counterparts in the House, as grumbling over Zika funding evolved from a partisan fight to a cameral one, too. "We're well along in this process," Blunt said. "I think the House is not where we are yet in terms of dealing with this issue and I'd like to see them get a little further along."
According to Graham, who's helping negotiate the package, it's not clear whether a deal would be unveiled before the Senate departs on Friday for a week-long recess.
AT HOUSE E&C TODAY: OPIOID MARKUP CONTINUES - The committee at 10 a.m. resumes its multi-day markup of 12 bills intended as a counterpart to the Senate's CARA legislation. Rep. Frank Pallone on Tuesday said he hoped the package could pass the committee this week and be brought to the House floor in May.
Details: http://go.politicoemail.com/?qs=b4f8aeb80d0765d9aafe64599ca8815b305fa9118f959be7eb05370c4fd15c8f
GROUPS LOBBY SENATE AG APPROPRIATORS ON DRUG COMPOUNDING - Six groups are calling on Senate appropriators today to ensure that the language in the FY 2017 agricultural spending bill "does not impede FDA's ability to ensure patient safety" by hampering new guidance on drug compounding.
The groups - an unusual coalition that includes the American Public Health Association, Biotechnology Industry Organization, Generic Pharmaceutical Association, Pew Charitable Trusts, Pharmaceutical Research and Manufacturers of America and Trust for America's Health - urge Sens. Thad Cochran, Barbara Mikulski, Jerry Moran and Jeff Merkley to avoid creating exemptions to the FDA's recent draft guidance on compounding.
"As the fungal meningitis outbreak demonstrates, access to compounded medicines must not come at the expense of quality and patient safety," the groups write in a letter.
Read the letter: http://go.politicoemail.com/?qs=b4f8aeb80d0765d972474b04cbd6baec5ab945311188eb050c7a7020d48b834a
UNITEDHEALTH'S OBAMACARE EXIT: THE COST OF BAD PRICING? - The nation's largest insurer is pulling out of dozens of state marketplaces this year, saying that it's losing money on its Obamacare plans. But a Kaiser Family Foundation expert argues that United only has itself to blame.
"The thing is, this really says more about UnitedHealthcare than it does about the ACA," Larry Levitt writes in the JAMA Forum. "The company's plans were often not competitively priced, with UnitedHealthcare offering 1 of the 2 lowest premium plans in only 35 percent of the counties where it participated."
More from Levitt: http://go.politicoemail.com/?qs=b4f8aeb80d0765d92e27042dc64ef89531434da6d1c3f5acc830951222e2a1c9
See KFF's state-by-state analysis of UnitedHealthcare's exchange participation: http://go.politicoemail.com/?qs=b4f8aeb80d0765d97e57233db99c7565022c534f367224cff0a41927fd3b1f97
ICYMI: CENTENE'S OBAMACARE SUCCESS STORY - The Medicaid health plan operator closed the first quarter with 680,000 exchange customers in 15 states, says it's turning a profit on the ACA exchanges and isn't ruling out expanding into additional markets, CEO Michael Neidorff said on an investor call yesterday. "Centene's exchange experience continues to be favorable," he stressed.
- Don't expect Centene to step in where United fell out, however. The two companies pursued different patient populations on the exchange, Neidorff said, with United customers opting for broader, more expensive plans than the low-price plans that Centene usually offers. "They're in a different market than we are, from what I can see," Neidorff pointed out.
- Wall Street liked Centene's news. The company's stock price traded up more than 6 percent yesterday, a tidy $500 million bump in Centene's market capitalization.
WONK OUT: 400-PLUS PAGES OF NATIONAL HEALTH CARE STATISTICS - A comprehensive annual report out from CDC this morning offers loads of national data on everything from coverage expansion and electronic health record adoption to use of colorectal tests and the number of dentists by state. CDC calls it the "report card on the nation's health," but it's essentially an encyclopedia crammed with information on trends across health care. It's accompanied by a special feature on disparities.
Read the report: http://go.politicoemail.com/?qs=b4f8aeb80d0765d9e14d67458a45135e651821f0215b4028990979b1c7733406
** A message from PhRMA: Biopharmaceutical intellectual property (IP) protections, such as patents, provide the incentives that spur research and development and lead to lifesaving treatments and cures. Learn more here about the outcome of strong IP policies. **
THIS MORNING: DOCTORS WITHOUT BORDERS PETITIONS PFIZER - The humanitarian group will place 2,500 flowers in an empty crib outside the drug maker's headquarters in New York City, as part of an ongoing protest.
What's behind the dramatic gesture? Doctors Without Borders says the flowers represent the number of children who die from pneumonia around the world each day, although the number would be lower if Pfizer and GlaxoSmithKline sliced the price of the pneumonia vaccine to $5 per child.
U.S. GETTING MORE PREPARED FOR EMERGENCIES, BUT SOME STATES LAG - That's according to a new RWJF survey that found a wide range in how states are prepared to handle health emergencies. Overall, the United States scored 6.7 in a 10-point preparedness index, a 3.6 percent increase since the survey launched in 2013.
One reason why preparedness matters: The threat of Zika virus this summer, especially in Southern states. Many states that could be affected by the virus lagged in the survey, and while much still isn't known about Zika, "we do know [that] having adequate lab testing for this type of virus is important," says Glen Mays, the University of Kentucky professor overseeing the survey. "Not all states have that capability."
See the report: http://go.politicoemail.com/?qs=b4f8aeb80d0765d925d659100843f44139b34eb69743fffb60cd0a218bdc60d3
States that are the most prepared
. Maryland (7.6)
. New York (7.5)
. Minnesota (7.4)
States that are the least prepared
. Louisiana (5.6)
. Montana (5.7)
. Arizona, Mississippi (5.8)
HOW SLOW YOU'LL GET - An interactive tool developed by a Yale economist is intriguing, if depressing: It predicts how much you'll lose off your peak swimming and running times as you age. Enter your data, if you dare: http://go.politicoemail.com/?qs=b4f8aeb80d0765d97543746967f3868eaac73cadaedc7a0519f90f1c57ac069b (via the NYT's Gina Kolata)
WHY NO PUERTO RICO? - Yesterday's PULSE reported on Leapfrog Group's latest hospital rankings, which found that Washington, D.C.'s hospitals ranked the worst overall on quality and safety. But one reader was less concerned by the poor performance of D.C., and more attuned to which territory was MIA - as usual.
"I was surprised that D.C., not Puerto Rico, appeared dead last in the survey," former Puerto Rico Secretary of State Kenneth McClintock writes PULSE. "Then I read the fine print - even though Puerto Rico is part of our nation's health system with six times more population than D.C., Puerto Rico was excluded."
HAVE YOU HEARD THE WORD? - Stay tuned.
WHAT WE'RE READING
HHS is set to expand the National Diabetes Prevention Program, and leaders from the American Diabetes Association, American Medical Association, YMCA and Omada Health explain why the initiative matters: http://go.politicoemail.com/?qs=b4f8aeb80d0765d9c8d491e1d639e817ba0ba645dae683adab766c6cd4b4edfc
Vox's Julia Belluz on how "Big Tissue" is engaged in a PR war to make us think that bathroom hand dryers spread disease: http://go.politicoemail.com/?qs=b4f8aeb80d0765d90cc2e8246fe16db680fc65b741c709b35457da20fc9966e5
Seniors are taking far too many supplements, Aaron Carroll warns in a new episode of "Healthcare Triage": http://go.politicoemail.com/?qs=b4f8aeb80d0765d9a5139e50adf6f9c407c0a1122b5d24c99d418bbf06afd03a
Hospitals' Medicare margins are down to negative 9 percent this year, according to a MedPAC study that Modern Healthcare's Dave Barkholz flagged: http://go.politicoemail.com/?qs=b4f8aeb80d0765d9a1e4bee3457f93b14da194d106ac2c665f05776aff11f94f
An outbreak of yellow fever has sickened 1,000 people - and it was totally preventable, WIRED's Sarah Zhang writes: http://go.politicoemail.com/?qs=b4f8aeb80d0765d93282132d7d2517624316b6510bc236c6529360b25a2eb687
** A message from PhRMA: Take a moment to consider the impact that strong and robust IP policies have on our daily lives and on the country. Due to the complexity of developing a medicine, strong IP protections are necessary to ensure that innovative biopharmaceutical companies are able to secure resources for future investments in research, giving hope to patients who await tomorrow's medicines. Learn more here about the outcome of strong IP policies. **
To view online:
http://go.politicoemail.com/?qs=b4f8aeb80d0765d9d8ac70e16839457afcbfbfccbb8d15c85a86951972423e9b
To change your alert settings, please go to http://go.politicoemail.com/?qs=b4f8aeb80d0765d92366ae1bb22e6fd8a0def7f71e3bfd0bed9d32fd825711f6 or http://click.politicoemail.com/profile_center.aspx?qs=57cf03c73f21c5ef65b9c058ca0f6cfa66691761e73177ec92fc4530edd994c720d06081dc1720bb613e150dfa270b4951b3344c557fc849This email was sent to [email protected] by: POLITICO, LLC 1000 Wilson Blvd. Arlington, VA, 22209, USA
To unsubscribe,http://www.politico.com/_unsubscribe?e=00000154-5805-d9db-a7dd-db2751ba0000&u=0000014e-f112-dd93-ad7f-f917a8270002&s=a0e1fcb13dab27bc30564b3a0864ec48c89fde72325d5e1d3f34bef1b42984c5850d888360a76b895a7725ec4f25a2a6ca818daacd6937c156c26f8bda31574d
ℹ️ Document Details
SHA-256
8fd32d9b7207ef218c7cf92f3cae07d0d3d7ac577e5b83604d4ff7094b4a8a48
Dataset
dnc-emails
Document Type
email
Comments 0